Berberine could treat eczema-exacerbated staph infections, suggests study Dr. Kamal Kant Kohli27 Jun 2024 8:00 PM ISTAtlanta: Eczema, a skin inflammatory disease that causes dry, itchy and inflamed skin, affects millions worldwide.Eczema is associated with an altered...
JnJ completes acquisition of Proteologix Ruchika Sharma23 Jun 2024 1:30 PM ISTNew Brunswick: Johnson & Johnson has announced that it has successfully completed the acquisition of Proteologix, Inc., a privately-held...
Crisaborole may Sustain Effective Control in Atopic Dermatitis, finds study Jacinthlyn Sylvia21 Jun 2024 6:30 AM ISTManaging atopic dermatitis (AD) often proves to be a persistent challenge in dermatological practice, with treatments frequently falling short in...
FDA approves single dose autoinjector for atopic dermatitis Dr. Kamal Kant Kohli14 Jun 2024 7:45 PM ISTThe US food and Drug Administration has approved a new 300 mg single-dose autoinjector for tralokinumab-ldrm (Adbry) for adults with...
Can high sodium diet increase risk of eczema? Dr. Kamal Kant Kohli6 Jun 2024 9:00 PM ISTUCSF Study finds that changes in daily salt intake may explain eczema flares. A high sodium diet may increase the risk of eczema, according to...
Upadacitinib Outperforms Dupilumab in Treating Atopic Dermatitis: Study Dr Riya Dave4 Jun 2024 8:00 PM ISTResearchers have found that upadacitinib (Rinvoq) was more effective than dupilumab (Dupixent) in treating moderate-to-severe atopic dermatitis in a...
JnJ to buy rights to Numab Therapeutics Clinical-Stage Bispecific Antibody NM26 Ruchika Sharma29 May 2024 12:30 PM ISTNew Brunswick: Johnson & Johnson has announced that it has entered into a definitive agreement with Numab Therapeutics, a clinical-stage...
Johnson & Johnson to acquire Proteologix for USD 850 million in cash Ruchika Sharma20 May 2024 4:23 PM ISTNew Brunswick: Johnson & Johnson has announced that it has entered into a definitive agreement to acquire Proteologix, Inc., a privately-held...
Submit preliminary analysis of primary data of subjects above 18 years in India: CDSCO Panel Tells Sanofi on Amlitelimab study Dr. Divya Colin19 May 2024 6:00 PM ISTNew Delhi: After considering the phase III clinical study protocol of the monoclonal antibody Amlitelimab in the treatment of moderate-to-severe...
A tailored vaccine could one day treat eczema in children-new research Dr. Kamal Kant Kohli17 May 2024 8:45 PM ISTNew research from a multi-disciplinary team at Trinity College Dublin suggests a "tailored vaccine" might hold the key to treating bacteria-driven...
Higher number of biologics required for control of coexisting PsA and atopic dermatitis: Study Jacinthlyn Sylvia13 May 2024 6:45 AM ISTA recent study published in the Journal of Personalized Medicine observed new insights regarding the treatment of psoriatic arthritis (PsA) and its...
Ruxolitinib Cream Shows Promise in Treating Adolescent Atopic Dermatitis: Study Medha Baranwal10 May 2024 9:30 PM ISTUSA: In a groundbreaking development in dermatology, the efficacy, safety, and long-term disease control of Ruxolitinib Cream among adolescents with...
